Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Jun;34(6):1014–1016. doi: 10.1128/aac.34.6.1014

Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.

R Dworkin 1, G Modin 1, S Kunz 1, R Rich 1, O Zak 1, M Sande 1
PMCID: PMC171748  PMID: 2393259

Abstract

The efficacies of the quinolones ciprofloxacin and pefloxacin alone and in combination with rifampin were compared with those of vancomycin alone and in combination with rifampin in a rat model of chronic osteomyelitis caused by methicillin-resistant Staphylococcus aureus. Neither the quinolones nor vancomycin alone was effective in reducing titers of organisms in bone after therapy, while rifampin alone was effective. All combination regimens with rifampin were more effective than the regimen with rifampin alone was, although these differences did not achieve statistical significance. Rifampin-resistant isolates were detected rarely. Quinolone-rifampin combination regimens may offer a nonparenteral option for the treatment of chronic osteomyelitis caused by methicillin-resistant S. aureus.

Full text

PDF
1014

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black J., Hunt T. L., Godley P. J., Matthew E. Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis. J Infect Dis. 1987 May;155(5):968–972. doi: 10.1093/infdis/155.5.968. [DOI] [PubMed] [Google Scholar]
  2. Cole W. G., Dalziel R. E., Leitl S. Treatment of acute osteomyelitis in childhood. J Bone Joint Surg Br. 1982;64(2):218–223. doi: 10.1302/0301-620X.64B2.6802854. [DOI] [PubMed] [Google Scholar]
  3. Eng R. H., Smith S. M., Tillem M., Cherubin C. Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection. Arch Intern Med. 1985 Jan;145(1):146–148. doi: 10.1001/archinte.145.1.146. [DOI] [PubMed] [Google Scholar]
  4. Fass R. J., Helsel V. L. In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs. Antimicrob Agents Chemother. 1987 Oct;31(10):1457–1460. doi: 10.1128/aac.31.10.1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hackbarth C. J., Chambers H. F., Sande M. A. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother. 1986 Apr;29(4):611–613. doi: 10.1128/aac.29.4.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Henry N. K., Rouse M. S., Whitesell A. L., McConnell M. E., Wilson W. R. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. Am J Med. 1987 Apr 27;82(4A):73–75. [PubMed] [Google Scholar]
  7. Kolyvas E., Ahronheim G., Marks M. I., Gledhill R., Owen H., Rosenthall L. Oral antibiotic therapy of skeletal infections in children. Pediatrics. 1980 May;65(5):867–871. [PubMed] [Google Scholar]
  8. Kotilainen P., Nikoskelainen J., Huovinen P. Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis. 1990 Jan;161(1):41–44. doi: 10.1093/infdis/161.1.41. [DOI] [PubMed] [Google Scholar]
  9. Norden C. W. Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S491–S494. doi: 10.1093/clinids/5.supplement_3.s491. [DOI] [PubMed] [Google Scholar]
  10. Norden C. W., Shaffer M. Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin. J Infect Dis. 1983 Feb;147(2):352–357. doi: 10.1093/infdis/147.2.352. [DOI] [PubMed] [Google Scholar]
  11. Rissing J. P., Buxton T. B., Weinstein R. S., Shockley R. K. Model of experimental chronic osteomyelitis in rats. Infect Immun. 1985 Mar;47(3):581–586. doi: 10.1128/iai.47.3.581-586.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schaefler S. Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. J Clin Microbiol. 1989 Feb;27(2):335–336. doi: 10.1128/jcm.27.2.335-336.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Simon G. L., Smith R. H., Sande M. A. Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S507–S508. doi: 10.1093/clinids/5.supplement_3.s507. [DOI] [PubMed] [Google Scholar]
  14. Wehrli W. Rifampin: mechanisms of action and resistance. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S407–S411. doi: 10.1093/clinids/5.supplement_3.s407. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES